| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8B | $6.7B | $6.7B | $6.4B | $6.3B | $1.6B | $1.5B | $1.5B |
| Cost of Revenue | $4.2B | $4.1B | $4.2B | $4.1B | $3.8B | $3.3B | $3.2B | $3.0B |
| Gross Profit | $2.6B | $2.6B | $2.5B | $2.3B | $2.5B | $0.7B | $0.6B | $0.7B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.5B | $1.5B | $1.5B | $1.4B | $1.4B | $1.3B | $1.2B | $1.4B |
| Operating Income | $1.1B | $1.1B | $1.0B | $0.9B | $1.0B | $0.3B | $0.3B | $0.3B |
| Net Income | $0.8B | $0.8B | $0.7B | $0.7B | $0.8B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $2.94 | $2.94 | $2.54 | $2.54 | $2.83 | $0.75 | $1.60 | $1.62 |
| EPS (Diluted) | $2.93 | $2.92 | $2.52 | $2.52 | $2.80 | $0.74 | $1.59 | $1.60 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $13.1B | $12.9B | $13.1B | $12.9B | $12.1B | $10.4B | $10.3B |
| Current Assets | $2.1B | $2.1B | $2.0B | $2.4B | $2.2B | $2.1B | $1.6B | $1.5B |
| Cash & Equivalents | $0.1B | $0.2B | $0.2B | $0.3B | $0.4B | $0.4B | $0.2B | $0.1B |
| Total Liabilities | $7.4B | $7.8B | $7.8B | $8.4B | $8.5B | $8.1B | $6.9B | $7.1B |
| Current Liabilities | $3.1B | $2.9B | $3.1B | $3.4B | $3.2B | $3.0B | $2.2B | $2.0B |
| Stockholders' Equity | $5.7B | $5.3B | $5.1B | $4.7B | $4.4B | $3.9B | $3.4B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.9B | $1.2B | $0.7B | $0.8B | $1.0B | $0.9B | $0.8B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.3B | $-0.1B | $-0.9B | $-1.0B | $-0.2B | $-0.2B |
| Capital Expenditures | — | — | — | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.8B | $-0.6B | $-1.2B | $-0.5B | $0.0B | $0.2B | $-0.7B | $-0.8B |